Technical Analysis for IGMS - IGM Biosciences, Inc.

Grade Last Price % Change Price Change
F 7.96 3.38% 0.26
IGMS closed up 3.38 percent on Wednesday, April 24, 2024, on 2.6 times normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
Earnings due: May 10
*** please verify all earnings dates ***
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
200 DMA Resistance Bearish 0.00%
Shooting Star Candlestick Bearish 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Slingshot Bearish Bearish Swing Setup 3.38%
Stochastic Buy Signal Bullish 3.38%

   Recent Intraday Alerts

Alert Time
Possible Pocket Pivot about 6 hours ago
10 DMA Resistance about 6 hours ago
200 DMA Resistance about 8 hours ago
Rose Above 10 DMA about 8 hours ago
20 DMA Resistance about 8 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Headquartered in Mountain View, California, IGM Biosciences is a biotechnology company focused on creating and developing engineered IgM antibodies for the treatment of cancer patients. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Immunology Antibodies Treatment Of Cancer Glycoproteins Biochemistry Protein Engineering Immunoglobulin M

Is IGMS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 17.7
52 Week Low 3.81
Average Volume 266,562
200-Day Moving Average 8.56
50-Day Moving Average 10.74
20-Day Moving Average 8.56
10-Day Moving Average 8.13
Average True Range 0.86
RSI (14) 41.86
ADX 14.49
+DI 27.69
-DI 28.96
Chandelier Exit (Long, 3 ATRs) 8.28
Chandelier Exit (Short, 3 ATRs) 9.27
Upper Bollinger Bands 10.15
Lower Bollinger Band 6.97
Percent B (%b) 0.31
BandWidth 37.21
MACD Line -0.77
MACD Signal Line -0.76
MACD Histogram -0.0132
Fundamentals Value
Market Cap 261.83 Million
Num Shares 32.9 Million
EPS -4.90
Price-to-Earnings (P/E) Ratio -1.62
Price-to-Sales 408.54
Price-to-Book 3.34
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.33
Resistance 3 (R3) 9.41 9.03 9.10
Resistance 2 (R2) 9.03 8.69 8.99 9.02
Resistance 1 (R1) 8.50 8.47 8.77 8.42 8.95
Pivot Point 8.12 8.12 8.26 8.08 8.12
Support 1 (S1) 7.59 7.78 7.86 7.51 6.97
Support 2 (S2) 7.21 7.56 7.17 6.90
Support 3 (S3) 6.68 7.21 6.82
Support 4 (S4) 6.60